A Study of JNJ-70033093 (BMS-986177) in Healthy Chinese Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 8, 2021

Primary Completion Date

December 4, 2021

Study Completion Date

December 16, 2021

Conditions

Healthy

Interventions

DRUG

JNJ-70033093

JNJ-70033093 capsule will be administered orally as per assigned treatment regimen.

Trial Locations (1)

West China Hospital Si Chuan University, Chengdu

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY

NCT04569695 - A Study of JNJ-70033093 (BMS-986177) in Healthy Chinese Adult Participants | Biotech Hunter | Biotech Hunter